Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenarios

The International Journal on Drug Policy
Lynn T Kozlowski

Abstract

Some major national and international tobacco control organisations favour mandating a reduction in nicotine content of cigarettes to non-addictive levels as a tobacco control tool. Reducing nicotine content, it is argued, will make tobacco smoking less attractive. The 2009 U.S. Food and Drug Administration's regulation of cigarettes appears to have the power to reduce nicotine to non-addictive levels provided it is not taken to zero. A consideration of the U.S. context, however, raises doubts about (a) whether this will ever be practicable and (b), if practicable, how long it will take to implement. Current versions of the nicotine-reducing strategy propose the systematic, incentivised use of less harmful nicotine/tobacco products as elements of the mandatory cigarette nicotine-reduction strategy. Time will tell if and when mandatory nicotine reduction in tobacco cigarettes will occur and what impact it might have on smoking prevalence. The question posed here is "Why wait?" Resources used in implementing reduction in nicotine content have an opportunity cost. In the meantime, nicotine-maintaining harm reduction strategies can have nearer term effects on tobacco use as an individual and a public health issue.

References

Jul 14, 1994·The New England Journal of Medicine·N L Benowitz, J E Henningfield
Aug 31, 1999·Tobacco Control·S Shatenstein
Sep 9, 1999·Tobacco Control·L Joossens, A Hayes
Jan 5, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·J E Henningfield, R V Fant
Mar 16, 2006·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·William G ShadelRobert Hornik
Aug 26, 2006·Drug and Alcohol Dependence·Andrew A StrasserEric A Feldman
Dec 14, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andrew A StrasserE Paul Wileyto
Aug 11, 2007·The International Journal on Drug Policy·David SweanorErnest Drucker
Sep 29, 2007·Cardiovascular Toxicology·Daniel F CatanzaroBabette B Weksler
Jul 17, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Karen M BeckerAnthony P Albino
Sep 11, 2008·Tobacco Control·A A StrasserJ N Cappella
Jun 23, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Mark ParascandolaStephen Marcus
Aug 19, 2009·Annals of the New York Academy of Sciences·Donald A Wilson
Mar 17, 2011·American Journal of Preventive Medicine·Michael B SiegelDavid E Nelson
Dec 21, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Scott J LeischowCathy L Backinger
Dec 24, 2011·Annals of the New York Academy of Sciences·Daniel N Wilson
Feb 22, 2012·Tobacco Control·Ann McNeillCoral Gartner
Oct 2, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Nigel Gray, Ron Borland
Oct 27, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Dorothy K HatsukamiMitch Zeller
Mar 15, 2013·Tobacco Control·Gregory N Connolly, Hillel R Alpert
Mar 16, 2013·Psychopharmacology·Kenneth A Perkins, Joshua L Karelitz
Apr 23, 2013·Tobacco Control·Neal L Benowitz, Jack E Henningfield
May 8, 2013·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Ingeborg Lund, Janne Scheffels
Dec 18, 2013·American Journal of Public Health·Shelley D GoldenKrista M Perreira
Feb 5, 2014·Annals of Internal Medicine·Linda L HumphreyChristopher G Slatore
Aug 26, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·David Hammond, Richard J O'Connor
Aug 27, 2014·Circulation·Aruni BhatnagarUNKNOWN American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinica
Feb 20, 2012·Tobacco Use Insights·David M PenetarScott E Lukas

❮ Previous
Next ❯

Citations

Nov 18, 2015·Current Problems in Pediatric and Adolescent Health Care·Rosemarie Fernandez, James A Grand
Jun 16, 2015·Israel Journal of Health Policy Research·David B Abrams, Raymond Niaura
Apr 22, 2015·The International Journal on Drug Policy·Kirsten Bell, Gerry V Stimson
Oct 4, 2017·Tobacco Control·David T LevyDavid B Abrams
Feb 20, 2019·International Journal of Environmental Research and Public Health·Rachelle Annechino, Tamar M J Antin
Oct 5, 2018·Harm Reduction Journal·Ariela Braverman-BronsteinTonatiuh Barrientos-Gutierrez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Neal L BenowitzPeyton Jacob
The New England Journal of Medicine
D A KesslerW B Schultz
© 2021 Meta ULC. All rights reserved